A new analysis shows no clear link between paternal valproate use and harm in offspring, raising questions about the EMA ...

A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

Beacon Therapeutics recently announced positive six-month interim safety and efficacy results from the Phase 2 DAWN trial of ...

Dr. Chung brings over three decades of experience spanning clinical ophthalmology, academic research and gene therapy developmentLONDON and CAMBRIDGE, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Beacon T ...

Avanzanite Bioscience B.V. ("Avanzanite"), a fast-growing commercial-stage specialty pharmaceutical company dedicated to ...